Roopa Industries Ltd Stock Price Today (NSE: ROOPAIND)
Fundamental Score
Roopa Industries Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Roopa Industries Ltd share price today is ₹52.48, down 0.79% on NSE/BSE as of 23 June 2026. Roopa Industries Ltd (ROOPAIND) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹39.26 (Cr). The 52-week high for ROOPAIND share price is ₹63.40 and the 52-week low is ₹38.10. At a P/E ratio of 20.45x, ROOPAIND is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 12.07% and a debt-to-equity ratio of 1.98.
Roopa Industries Ltd Share Price Chart — NSE/BSE Historical Performance
Roopa Industries Ltd share price chart: -4.75% return over the past month. 52-week high ₹63.40, 52-week low ₹38.10.
Roopa Industries Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹52.45 | ₹52.64 | ₹52.24 | ₹52.48 | 1.05K (Cr) | |
| ₹52.00 | ₹53.00 | ₹49.66 | ₹52.90 | 1.21K (Cr) | |
| ₹51.53 | ₹51.53 | ₹51.53 | ₹51.53 | 0.00 (Cr) | |
| ₹51.60 | ₹51.60 | ₹50.00 | ₹51.53 | 830.00 (Cr) | |
| ₹54.51 | ₹54.51 | ₹50.06 | ₹51.60 | 556.00 (Cr) | |
| ₹51.03 | ₹53.98 | ₹51.03 | ₹53.98 | 4.00 (Cr) | |
| ₹51.02 | ₹51.03 | ₹51.02 | ₹51.03 | 35.00 (Cr) | |
| ₹50.01 | ₹54.89 | ₹50.01 | ₹53.97 | 409.00 (Cr) | |
| ₹52.50 | ₹52.50 | ₹52.48 | ₹52.48 | 8.00 (Cr) | |
| ₹54.24 | ₹54.24 | ₹50.87 | ₹53.94 | 79.00 (Cr) |
Roopa Industries Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹52.00 | ₹53.00 | ₹49.66 | ₹52.48 | +0.92% | |
| ₹59.99 | ₹59.99 | ₹50.00 | ₹51.53 | -14.10% | |
| ₹43.47 | ₹63.40 | ₹39.00 | ₹60.48 | +39.13% | |
| ₹48.90 | ₹57.99 | ₹38.10 | ₹39.19 | -19.86% | |
| ₹47.75 | ₹52.00 | ₹42.26 | ₹45.77 | -4.15% | |
| ₹44.04 | ₹50.90 | ₹41.00 | ₹45.49 | +3.29% | |
| ₹47.40 | ₹53.85 | ₹41.34 | ₹44.04 | -7.09% | |
| ₹53.99 | ₹56.80 | ₹43.00 | ₹49.28 | -8.72% | |
| ₹56.70 | ₹59.80 | ₹50.21 | ₹51.42 | -9.31% | |
| ₹56.04 | ₹59.00 | ₹50.75 | ₹53.85 | -3.91% | |
| ₹58.98 | ₹59.15 | ₹49.06 | ₹56.94 | -3.46% | |
| ₹58.50 | ₹62.62 | ₹54.00 | ₹55.05 | -5.90% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Roopa Industries Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Roopa Industries Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ROOPAIND across key market metrics for learning purposes.
Positive Indicators
5 factors identified
Attractive Valuation (P/E: 20.45 vs Industry: 31.77)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Consistent Growth Track Record (34.28% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (40.00% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (40.00% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Profit Decline Concern (-20.69%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Elevated Debt Levels (D/E: 1.98)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (1.88x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-5.59 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.25%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Roopa Industries Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Roopa Industries Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Roopa Industries LtdRoopa Industrie...Selected✓ ROOPAIND • 530991 | 47.8/100 | ₹52.48₹52 | ₹39.26₹39.26 | 20.45Average 20.4 Average | 12.07%Average 12.07% Average | 11.96%Average 11.96% Average | 1.98Average 2.0 Average | 40.00%Excellent 40.00% Excellent | 34.28%Excellent 34.28% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 65.2/100 | ₹1844.30₹1844 | ₹433738.68₹433738.68 | 37.57Average 37.6 Average | 16.86%Good 16.86% Good | 20.21%Excellent 20.21% Excellent | 0.07Excellent 0.1 Excellent | 23.78%Excellent 23.78% Excellent | 9.87%Good 9.87% Good | 0.89% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 67.9/100 | ₹6797.50₹6798 | ₹170445.88₹170445.88 | 68.59Average 68.6 Average | 15.35%Good 15.35% Good | 20.44%Excellent 20.44% Excellent | 0.01Excellent 0.0 Excellent | 10.41%Good 10.41% Good | 11.65%Good 11.65% Good | 0.47% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 65.3/100 | ₹4537.80₹4538 | ₹126430.62₹126430.62 | 58.36Average 58.4 Average | 26.52%Excellent 26.52% Excellent | 27.05%Excellent 27.05% Excellent | 0.33Excellent 0.3 Excellent | 13.84%Good 13.84% Good | 7.72%Good 7.72% Good | 0.86% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 59/100 | ₹1418.20₹1418 | ₹123059.76₹123059.76 | 22.62Average 22.6 Average | 17.77%Good 17.77% Good | 22.72%Excellent 22.72% Excellent | 0.01Excellent 0.0 Excellent | 28.68%Excellent 28.68% Excellent | 9.97%Good 9.97% Good | 0.85% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 59.2/100 | ₹1319.00₹1319 | ₹105224.96₹105224.96 | 18.23Average 18.2 Average | 17.96%Good 17.96% Good | 22.69%Excellent 22.69% Excellent | 0.16Excellent 0.2 Excellent | 22.28%Excellent 22.28% Excellent | 13.26%Good 13.26% Good | 0.63% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 66.7/100 | ₹2276.40₹2276 | ₹95148.15₹95148.15 | 22.00Average 22.0 Average | 20.62%Excellent 20.62% Excellent | 21.30%Excellent 21.30% Excellent | 0.32Excellent 0.3 Excellent | 54.88%Excellent 54.88% Excellent | 8.11%Good 8.11% Good | 0.58% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 68.7/100 | ₹956.95₹957 | ₹94253.78₹94253.78 | 18.74Average 18.7 Average | 21.21%Excellent 21.21% Excellent | 24.31%Excellent 24.31% Excellent | 0.38Excellent 0.4 Excellent | 25.92%Excellent 25.92% Excellent | 10.27%Good 10.27% Good | 1.17% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 50.6/100 | ₹2420.40₹2420 | ₹92012.53₹92012.53 | 52.62Average 52.6 Average | 14.68%Average 14.68% Average | 15.98%Good 15.98% Good | 0.55Good 0.6 Good | 11.73%Good 11.73% Good | 15.79%Excellent 15.79% Excellent | 0.04% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 28.8/100 | ₹1435.90₹1436 | ₹70798.69₹70798.69 | 20.69Average 20.7 Average | 11.08%Average 11.08% Average | 14.18%Average 14.18% Average | 0.22Excellent 0.2 Excellent | 3.87%Average 3.87% Average | 6.55%Good 6.55% Good | 0.33% |
Alkem Laboratories LtdAlkem Laborator... ALKEM • 539523 | 59.5/100 | ₹5451.50₹5452 | ₹67075.29₹67075.29 | 28.54Average 28.5 Average | 19.39%Good 19.39% Good | 20.38%Excellent 20.38% Excellent | 0.18Excellent 0.2 Excellent | 13.93%Good 13.93% Good | 9.21%Good 9.21% Good | 0.80% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price433738.68 Cr
- Divis Laboratories Ltd share price170445.88 Cr
- Torrent Pharmaceuticals Ltd share price126430.62 Cr
- Cipla Ltd share price123059.76 Cr
- Dr Reddys Laboratories Ltd share price105224.96 Cr
Roopa Industries Ltd PE Ratio History
Historical price-to-earnings ratio for ROOPAIND — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.95 | ₹73.15 | 37.5x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Roopa Industries Ltd Quarterly Performance
Latest quarterly metrics for ROOPAIND — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
12.22%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-20.69%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
34.28%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
40.00%
Compounded annual net profit growth over 5 years
Roopa Industries Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ROOPAIND — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Roopa Industries Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Roopa Industries Ltd (ROOPAIND) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Roopa Industries Ltd
About ROOPAIND (Roopa Industries Ltd)
Roopa Industries Ltd is a dynamic player in the pharmaceutical landscape, deeply rooted in the production and distribution of essential chemical compounds. The company specializes ...in crafting a diverse portfolio of bulk drugs, complex intermediaries, and high-purity fine chemicals. Their operations bridge the critical gap between raw materials and finished pharmaceutical products, serving as a vital link in the global supply chain. Through rigorous research and development, Roopa Industries continuously strives to innovate and enhance its product offerings, ensuring they meet the evolving demands of the medical industry and contribute to improved healthcare solutions worldwide. Roopa Industries prides itself on its ability to synthesize a wide array of specialized chemicals, including intricate compounds like triphenyl phosphine and various glucosamine salts. These chemicals find applications in a multitude of pharmaceutical formulations and processes. Beyond these, Roopa Industries also provides critical components like abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, demonstrating a strong commitment to supplying crucial ingredients to their partners. Their robust manufacturing processes and strict quality control protocols guarantee product integrity and consistent performance. The company is dedicated to maintaining the highest standards throughout its production cycles. With its base of operations strategically situated in Hyderabad, India, Roopa Industries serves both domestic and international markets. Established in 1985, the company leverages decades of experience and a deep understanding of the chemical sector. It has worked to forge lasting relationships with its clients. Roopa Industries has built a reputation for reliability and responsiveness. Their commitment to customer satisfaction, coupled with their technical expertise, positions them as a trusted partner for pharmaceutical companies seeking premium-grade chemical solutions. The company's focus on sustainable practices and ethical business conduct further reinforces its commitment to responsible growth within the industry.
Company Details
Key Leadership
ROOPAIND Share Price: Frequently Asked Questions
What is the current share price of Roopa Industries Ltd?
Roopa Industries Ltd (ROOPAIND) trades at ₹52.48 on NSE and BSE. Market cap ₹39.26 (Cr). Educational data only.
What is the P/E ratio of Roopa Industries Ltd?
Roopa Industries Ltd has a P/E of 20.45x vs industry average 31.77x.
What is the Bull Run score for Roopa Industries Ltd?
Roopa Industries Ltd has a Bull Run score of 47.8/100 based on 25+ financial parameters.
Does Roopa Industries Ltd pay dividends?
Roopa Industries Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Roopa Industries Ltd?
Roopa Industries Ltd has ROE of 12.07%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Roopa Industries Ltd?
Roopa Industries Ltd has debt-to-equity of 1.98.
Is Roopa Industries Ltd a good investment?
Bull Run gives Roopa Industries Ltd a score of 47.8/100. This is not investment advice — consult a SEBI-registered advisor.